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Abstract
Background: Acute kidney injury (AKI) is increasingly recognized as a consequential clinical complication in
children with severe malaria. However, approaches to estimate baseline creatinine (bSCr) are not standardized in
this unique patient population. Prior to wide-spread utilization, bSCr estimation methods need to be evaluated in
many populations, particularly in children from low-income countries.
Methods: We evaluated six methods to estimate bSCr in Ugandan children aged 6 months to 12 years of age in
two cohorts of children with severe malaria (n = 1078) and healthy community children (n = 289). Using isotope
dilution mass spectrometry (IDMS)-traceable creatinine measures from community children, we evaluated the bias,
accuracy and precision of estimating bSCr using height-dependent and height-independent estimated glomerular
filtration (eGFR) equations to back-calculate bSCr or estimating bSCr directly using published or population-specific
norms.
Results: We compared methods to estimate bSCr in healthy community children against the IDMS-traceable SCr
measure. The Pottel-age based equation, assuming a normal GFR of 120 mL/min per 1.73m2, was the more accurate
method with minimal bias when compared to the Schwartz height-based equation. Using the different bSCr
estimates, we demonstrated the prevalence of KDIGO-defined AKI in children with severe malaria ranged from
15.6–43.4%. The lowest estimate was derived using population upper levels of normal and the highest estimate was
derived using the mean GFR of the community children (137 mL/min per 1.73m2) to back-calculate the bSCr.
Irrespective of approach, AKI was strongly associated with mortality with a step-wise increase in mortality across AKI
stages (p < 0.0001 for all). AKI defined using the Pottel-age based equation to estimate bSCr showed the strongest
relationship with mortality with a risk ratio of 5.13 (95% CI 3.03–8.68) adjusting for child age and sex.
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Conclusions: We recommend using height-independent age-based approaches to estimate bSCr in hospitalized
children in sub-Saharan Africa due to challenges in accurate height measurements and undernutrition which may
impact bSCr estimates. In this population the Pottel-age based GFR estimating equation obtained comparable bSCr
estimates to population-based estimates in healthy children.
Keywords: Acute kidney injury, Baseline creatinine, Schwartz, Pottel, Severe malaria, Sub-Saharan Africa, Methods,
Mortality, Undernutrition, Pediatric
Background
Globally, 1.7 million people die from acute kidney injury
(AKI) every year and 80% of deaths occur in low-and
middle-income countries (LMIC) [1]. Mortality from
AKI in children in sub-Saharan Africa is 34% compared
to a global average of 14% [2]. In contrast to high-
income countries where the majority of AKI is hospital-
acquired and managed in intensive care settings, the
majority of AKI in LMIC is community-acquired [3]. As
such, using admission creatinine to estimate baseline
SCr (bSCr) likely leads to AKI under-recognition. In a
study of Ugandan children with severe malaria with ser-
ial creatinine measures, half had their peak creatinine
measured on admission [4].
AKI is diagnosed by increased serum creatinine or de-
creased urine output [5]. Accurate diagnosis of AKI re-
lies on knowing bSCr which is ideally measured within 3
months of hospital admission. However, bSCr values are
often unavailable in hospitalized patients, requiring bSCr
estimation. A number of studies have evaluated ap-
proaches to estimate bSCr in pediatric populations in
high-income countries [6–8]. The most commonly used
approach is to assume a normal estimated glomerular
filtration rate (eGFR) of 120 mL/min per 1.73m2 and use
the Bedside Schwartz equation to back-calculate bSCr
[6, 8–10]. This approach has been used in large multi-
national studies [10], but has not been validated in
LMIC settings where there are limited population-based
estimates of creatinine in children.
Creatinine is affected by non-renal factors including
muscle mass and nutritional status [11]. It is import-
ant to validate approaches to estimate bSCr in LMIC
where undernutrition is more prevalent and lower es-
timated bSCr relative to height due to less muscle
mass per body surface area may result in eGFR being
overestimated [12]. Another challenge in using the
bedside Schwartz equation to back-calculate estimated
bSCr is the requirement for a height measurement.
Height measurements are not always available in
LMIC and it can be challenging to accurately measure
height in the context of critical illness. As such, the
development of validated height-independent ap-
proaches to estimate bSCr in LMIC would simplify
AKI diagnosis. Recently, there have been efforts to
measure creatinine and evaluate the burden of kidney
disease in adults in sub-Saharan Africa [13–16], but
data from pediatric populations are lacking [17].
In this study we evaluate six methods to estimate bSCr
in two cohorts of Ugandan children. We evaluated the
accuracy, bias and precision of methods to estimate
bSCr compared to measured values in healthy children.
In children with severe malaria, we evaluated the preva-
lence of AKI, and the relationship between AKI and
mortality. We hypothesize that standard methods to de-




We used two severe malaria cohorts that prospectively
recruited children in Uganda between 2008 and 2017,
and a population of healthy community children as
controls (Fig. 1). All children with severe malaria had P.
falciparum on blood smear or a positive rapid diagnos-
tic test for Plasmodium falciparum HRP-2, and met
World Health Organization criteria for severe malaria
[18]. Severe malaria was defined according to WHO
criteria: coma (Blantyre Coma Score < 3), deep breath-
ing, multiple convulsions, prostration, shock, abnormal
bleeding, and jaundice; and laboratory indices of disease
severity (severe anemia, hypoglycemia, hyperlactatemia,
hyperparasitemia) (Fig. 1) [18]. Cohort 1 enrolled
children meeting specific case definitions for cerebral
malaria or severe malarial anemia [19]. Cohort 1
enrolled children aged 18 months to 12 years of age
between 2008 and 2013 from Mulago National Referral
Hospital in Kampala, Uganda [19]. Cohort 2 enrolled
children with a broad range of severe malaria criteria:
cerebral malaria, respiratory distress, multiple seizures,
severe malarial anemia, or prostration. Cohort 2
enrolled children 6 months to 4 years of age between
2014 and 2017 from Mulago National Referral Hospital
in Kampala or Jinja Regional Referral Hospital in Jinja,
Uganda. Although children were enrolled in each study
on the basis of specific severe malaria criteria, multi-
organ dysfunction was common and children often
presented with multiple severe malaria criteria (Fig. 1).
Exclusion criteria included known chronic illness
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requiring medical care, known developmental delay, or
history of coma, head trauma, hospitalization for mal-
nutrition, or cerebral palsy. Additional exclusion cri-
teria for the community children (CC) included any
illness requiring medical care within the previous 4
weeks or major medical or neurologic abnormalities at
screening physical examination, including a known his-
tory of kidney and urinary tract birth defects, or
chronic renal disease. Community children with an
eGFR < 90 mL/min per 1.73m2 calculated from the en-
rollment serum creatinine were excluded (n = 2). Com-
munity children in both studies were recruited from
the nuclear family, extended family, or household area
of children with severe malaria.
At enrollment all children had a history and physical
exam and had blood drawn for clinical tests and EDTA-
anticoagulated plasma stored at − 80 °C until testing. Chil-
dren were weighed on a standardized electronic weighing
scale. Height was measured using a stadiometer (recum-
bent) or a wall-mounted tape measure (standing height).
Recumbent height was taken on all children with SM at
enrollment and standing at follow-up visits, while the
community children were assessed standing for all visits.
For cohort 2, the recumbent length was taken on all chil-
dren across visits. Heights and weights were converted
into z scores (height-for-age, weight-for-age, weight-
for-height or bmi-for-age) based on 2006 World
Health Organization (WHO) or 2007 WHO growth
references based on age taking into consideration
whether the measure was taken standing or recum-
bent [20, 21]. Undernutrition was defined as a z
score < − 2 as follows: underweight (weight-for-age),
stunting (height-for-age), or wasting (weight-for-
height or BMI-for-age). Children were tested for
sickle cell anemia as described [22]. A single blood
pressure reading was taken on enrollment for all chil-
dren using available instruments. As categorization of
blood pressure based on standardized percentiles re-
quires three independent measurements [23], we do
not present data on hypertension in the population.
Fig. 1 Flow chart of the two study populations. Between 2008 and 2017, 289 community children and 1078 children with severe malaria were
enrolled in two severe malaria studies that recruited children from Kampala and Jinja in Uganda. One community child from each cohort with
evidence of underlying kidney disease (estimated GFR < 90 mL/min per 1.73m2) was excluded from the study
Batte et al. BMC Nephrology          (2020) 21:417 Page 3 of 14
Quality review of height measurements
In both cohorts serial heights were measured over follow-
up. Children from cohort 1 had scheduled follow-up visits
at 6, 12 and 24months, and children from cohort 2 had
scheduled follow-up visits at 1month and 12months.
Heights were also measured on unscheduled sick visits
over follow-up. To identify within-subject height outliers,
linear mixed effects models were used and standardized
residuals were used to flag heights for further review [24,
25]. Models included height as the dependent variable and
age and sex as fixed effects with a subject specific random
intercept and slope. Cohort 1 flagged children with a stan-
dardized residual > 2 or < − 2 and cohort 2 used more
stringent criteria of > 1 or < − 1 as more frequent height
assessments were available for comparison. Heights
flagged were independently reviewed for trend over time
by two pediatricians (EPN and AB) using height-for-age
and weight-for-age z scores over time to identify outliers
and make adjustments consistent with the child’s individ-
ual growth trajectory (n = 22 adjustments, cohort 1; n = 15
adjustments, cohort 2). If heights were missing on admis-
sion, heights recorded at follow-up visits were used to
interpolate the missing enrollment values (n = 5, cohort 1;
n = 7, cohort 2). If height was missing and a follow-up
height was not available (e.g. death), missing heights were
estimated using WHO height-for-age reference curves
stratified by sex (n = 24) [20, 21]. When the heights for
both cohorts were plotted on WHO height-for-age refer-
ence curves, the curve for the population corresponded to
the 10th percentile. In instances admission heights were
missing without a follow-up height available, children
were assigned a height based on the 10th percentile for
the WHO curve (n = 19, cohort 1; n = 25, cohort 2). Ad-
mission heights when children were ill were noted as the
most difficult heights to accurately measure.
Assessing kidney function
Creatinine was tested on cryopreserved enrollment sam-
ples using a Beckman Coulter AU680 using the modified
Jaffe colorimetric method (Indiana University, Pathology
Laboratory). Samples were sent on dry ice to the research
laboratory at Indiana University, and then stored again at
-80C until sent to the Indiana University Pathology clin-
ical laboratory for creatinine testing between 2012 and
2014 (cohort 1) and 2018 (cohort 2). Acute kidney injury
was defined using the Kidney Disease: Improving Global
Outcomes (KDIGO) criteria [5]. AKI was defined as a 1.5-
fold increase in creatinine over estimated baseline and was
staged: stage 1, 1.5–1.9x increase in creatinine over base-
line; stage 2, 2.0–2.9x increase over baseline; stage 3, ≥3.0x
increase over baseline. A single creatinine measure was
available on admission and data on urine output were not
collected. Dialysis was not available on site at the time the
study was conducted.
Methods of estimating bSCr
Six methods of estimating bSCr were evaluated (Fig. 2).
First, we back-calculated estimated bSCr using an as-
sumed eGFR value and height-dependent (Bedside
Schwartz [26]) or height-independent (Pottel [27]) equa-
tions as shown below.
1. bSCrGFRSchwartz120 (AKISchwartz120): back-calculate
estimated bSCr using the Bedside Schwartz equa-
tion, where eGFR = (0.413*height)/SCr, assuming a
normal GFR of 120 mL/min per 1.73m2 (height-
dependent, reference).
2. bSCrGFRPottel120 (AKIPottel120): back-calculate esti-
mated bSCr using the Pottel age-based equation,
where eGFR = 107.3/(SCr/Q), assuming a normal
GFR of 120 mL/min per 1.73m2 (height-independ-
ent). Q = 0.0270*age + 0.2329.
3. bSCrGFRSchwartz137 (AKISchwartz137): back-calculate
bSCr using the Bedside Schwartz equation, where
eGFR = (0.413*height)/SCr, assuming a normal GFR
of 137 mL/min per 1.73m2 corresponding to the
population mean for healthy children.
We then used non-GFR based approaches to estimate
bSCr directly.
4. bSCrupperlimit: Estimate bSCr using published upper
limits of normal by age category (height-
independent) [28].
5. bSCrheightCC: Estimate bSCr using linear regression
models to estimate bSCr based on height-for-
creatinine data from the community children,
where y = 0.00276*height + 0.03607.
6. bSCrageCC: Estimate bSCr using linear regression
models to estimate bSCr based on age-for-
creatinine data from the community children,
where y = 0.02058*age + 0.2199.
Population-derived regression models were developed
in healthy community children (n = 239) without sickle
cell trait (HbAS, n = 40) or disease (HbSS, n = 1). See
Additional File for Figure S1 showing the regression
models for height- and age-based estimation of bSCr
using the community children.
Role of the funding source
The funders had no role in the study design, analysis or
decision to publish.
Statistical analysis
Data were analyzed using STATA v14.0 (StataCorp) and
GraphPad Prism v7.03. Differences between continuous
measures were analyzed using Student’s t-test or one-
way ANOVA, and differences in proportions were
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analyzed using Pearson’s Chi Square test or Fisher’s
exact test, as appropriate. To evaluate differences in the
measured vs. estimated baseline creatinine in community
children, Bland-Altman plots were generated. To com-
pare the difference between the measured and estimated
bSCr, we used a paired Wilcoxon signed rank test. Bias
was represented by the total mean difference between
estimated and measured creatinine, and compared to a
hypothetical value of 0 using a one-sample t-test. Preci-
sion represents one standard deviation of the bias. Pro-
portional bias was evaluated by testing if the slope of the
linear regression model of the differences between esti-
mated and measured creatinine against the average of
estimated and measured creatinine differed from zero
[29]. To evaluate accuracy, we compared the percentage
of estimated bSCr values that fell within 10% (p10) or
30% (p30) of the measured creatinine. Binomial exact
confidence intervals were used to estimate the 95% con-
fidence estimates for the AKI prevalence. To evaluate
the relationship between AKI and mortality we used
generalized linear models to estimate the risk ratio (RR)
using binomial family and log link adjusting for age and
sex. Model fit was assessed using Akaike information
criterion (AIC) and Bayesian information criterion (BIC).
Receiver operating characteristic (ROC) curves were also
used to evaluate the relationship between AKI and mor-
tality. A p value < 0.05 was considered significant.
Results
The present study prospectively enrolled children
from 2008 to 2013 (Cohort # 1, 18 months to 12 years
of age) and 2014–2018 (Cohort #2, 6 months to 4
years of age) (Fig. 1). The mean age (SD) of commu-
nity children was 3.3 (1.9) years compared to 2.8 (1.6)
years in children with severe malaria (Table 1). There
was a sex difference in community children compared
to children with severe malaria with 51.2% of com-
munity children female compared to 42.2% of chil-
dren with severe malaria. There was no difference in
height-for-age z scores between the community chil-
dren and children with severe malaria. Children with
severe malaria had lower weight-for-age and weight-
for-height z scores and were more likely to be under-
weight or wasted compared to community children
(Table 1). Overall, 24.7% of children were stunted,
17.7% underweight and 12.3% wasted.
Fig. 2 Overview of approaches used to evaluate estimates of baseline serum creatinine. a Overview of GFR-based and direct SCr-based methods
to estimate baseline serum creatinine (bSCr) in community children. Linear regression models using the height and age of community children
were used for direct estimation of ebSCrheightCC and ebSCrageCC. b The estimated bSCr and measured SCr were compared in community children
to evaluate the bias, precision and accuracy of methods. c AKI was defined in children with severe malaria using the different approaches to
estimate bSCr, and the relationship between AKI and mortality was evaluated
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Nutritional status affects creatinine levels and mal-
nourished children tend to have lower creatinine levels
and overestimate GFR [30]. When we calculated eGFR
using measured creatinine levels and the bedside
Schwartz equation in community children, the mean
eGFR in community children was 137 mL/min per
1.73m2, which is higher than the assumed normal GFR
of 120 mL/min per 1.73m2 that is used as assumed base-
line in pediatric AKI research [6, 8, 10].
The prevalence of sickle cell trait in Ugandan children
is estimated to be 13.3% and sickle cell disease 0.7% [31].
There were 49 (16.5%) community children with sickle
cell trait (HbAS) and one (0.3%) with sickle cell anemia
(HbSS). There were no differences in eGFR or measured
SCr in the community children based on the presence of
sickle cell trait (mean (SD): HbAA, 0.29 (0.08) vs. HbAS,
0.30 (0.07), p = 0.207; eGFR, HbAA, 137.7 (30.2) vs.
HbAS, 132.5 (27.7), p = 0.265).
Table 1 Demographic characteristics of study population







Cohort #1 (n = 172) Cohort #2 (n = 117) Combined (n = 289)
Enrollment years 2008–2013 2014–2017 2008–2017 2008–2017 –
Age, years
Mean (SD) 4.01 (2.03) 2.22 (1.02) 3.28 (1.91) 2.83 (1.62) 0.0001
Median (IQR) 3.59 (2.61, 4.62) 2.21 (1.39, 3.09) 3.00 (2.06, 3.92) 2.50 (1.75, 3.47)
Min, Max 1.55, 11.44 0.53, 3.96 0.53, 11.44 0.46, 11.69
Age category, n(%)
< 1 0 (0.0) 18 (15.4) 18 (6.2) 74 (6.9) 0.001
1- < 2 11 (6.4) 35 (29.9) 46 (15.9) 296 (27.5)
2–5 128 (74.4) 64 (54.7) 192 (66.4) 609 (56.5)
> 5 33 (19.2) 0 (0.0) 33 (11.4) 99 (9.2)
Sex, % F 94 (54.7) 55 (47.0) 149 (51.2) 455 (42.2) 0.004
Height, cm 96.6 (13.6) 83.7 (10.4) 91.4 (13.9) 88.8 (12.8) 0.0032
Weight, kg 14.7 (4.4) 11.6 (2.6) 13.5 (4.1) 12.0 (3.6) < 0.0001
BMI, kg/m2 15.6 (1.7) 16.5 (1.7) 15.9 (1.7) 15.1 (1.8) < 0.0001
Weight-for-agea −0.82 (0.98) − 0.47 (1.08) − 0.68 (1.04) −1.10 (1.10) < 0.0001
Underweighta n (%) 21 (12.5) 9 (7.7) 30 (10.5) 209 (19.6) < 0.0001
Height-for-ageb −1.25 (1.13) −1.26 (1.34) − 1.25 (1.22) −1.17 (1.35) 0.3602
Stunted, n (%) 43 (25.0) 36 (30.8) 79 (27.3) 259 (24.1) 0.250
Weight-for-height < 5c −0.15 (1.25) 0.30 (1.02) 0.05 (1.17) −0.65 (1.32) < 0.0001
BMI-for-age > 5d −0.30 (0.84) – −0.30 (0.84) − 0.80 (1.43) 0.0635
Wasted, n (%)e 8 (4.7) 3 (2.6) 11 (3.8) 156 (14.6) < 0.0001
Systolic BP 94.1 (10.2) 98.5 (11.7) 95.9 (11.1) 95.9 (13.0) 0.9164
Diastolic BP 60.9 (10.6) 59.1 (9.8) 60.2 (10.4) 56.9 (12.1) < 0.0001
Enrollment SCr
Mean ± SD 0.31 (0.08) 0.26 (0.07) 0.29 (0.08) 0.48 (0.48) < 0.0001
Median (IQR) 0.30 (0.24, 0.35) 0.25 (0.20, 0.30) 0.28 (0.23, 0.33) 0.38 (0.29, 0.49)
Min, Maxa 0.19, 0.56 0.19, 0.46 0.19, 1.0 0.19, 7.3
Enrollment eGFR, ml/min per 1.73m2 136.4 (29.3) 137.7 (30.5) 136.9 (29.8) 99.5 (38.2) < 0.0001
Data are presented as mean (SD) unless otherwise indicated. Undernutrition (weight-for-age z score < −2), stunted (height-for-age z score < −2), wasted (weight-
for-height or bmi-for-age z score < −2) according to WHO 2006 (age 0–5 years) and 2007 (5–12 years) reference standards
aWeight-for-age z scores available for children < 10 years (Cohort #1, CC n = 168, SM n = 476; Cohort #2, CC n = 117, SM n = 591; Combined, CC n = 285;
SM, n = 1067)
bHeight-for-age z scores (Cohort #1, CC n = 168, SM n = 479; Cohort #2, CC n = 117, SM n = 598; Combined, CC n = 289; SM, n = 1077)
cWeight-for-height z scores available for children < 5 years (Cohort #1, CC n = 139, SM n = 388; Cohort #2, CC n = 117, SM n = 591; Combined, CC n = 256;
SM, n = 979)
dBMI-for-age z scores available for children ≥5 years of age (Cohort #1, CC n = 33, SM = 91; Cohort #2, CC n = 0, SM n = 0; Combined, CC n = 33; SM, n = 91)
eWasted (Cohort #1, CC n = 172, SM = 479; Cohort #2, CC n = 117, SM n = 591; Combined, CC n = 289; SM, n = 1070)
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Approaches to estimate creatinine in community children
To evaluate the most appropriate approach to esti-
mate bSCr in this population (Fig. 2), we compared
the measured and estimated baseline creatinine and
eGFR in community children (Fig. 3). We evaluated
the bias, precision and accuracy of the different ap-
proaches to estimate bSCr against the measured
values in the community children using Bland-Altman
analysis (Table 2, Fig. 4). When comparing the mea-
sured vs. estimated bSCr values using a paired Wil-
coxon signed rank test, four methods had comparable
measured and estimated bSCr values: the height
(bSCrheightCC) and age-based (bSCrageCC) linear regres-
sion estimates as well as bSCrGFRSchwartz137 and
bSCrGFRPottel120. The same methods had the highest
accuracy with the percentage values within 10% of
the measured value ranging from 29 to 35% and the
percentage of values within 30% of the measured
value within 78–82% and three methods (bSCrheightCC,
bSCrageCC, bSCrGFRPottel120) did not show significant
bias (Table 2, Fig. 4). Two approaches over-estimated
bSCr: the upper limit of normal (bSCrupperlimit), and
bSCrGFRSchwartz120, which is the current standard in
pediatric AKI research. The estimated bSCr using the
mean of the community children (bSCrGFRSchwartz137)
was comparable to the measured value in the popula-
tion, but underestimated bSCr in infants. All methods
showed proportional bias in Bland-Altman analysis
with a significant slope of the regression line
comparing the difference and average between mea-
sured and estimated bSCr at higher creatinine values
(Table 2, Fig. 4).
As there are physiological increases in GFR from birth
to 2 years of age, using a single eGFR value across all
ages may not be appropriate and age-related normative
GFR values for children < 2 years of age have been used
in previous studies [8]. When eGFR was calculated using
the Bedside Schwartz equation from bSCrGFRPottel120 or
directly from estimated bSCr (bSCrupperlimit, bSCrheightCC,
bSCrageCC) there was an increase in GFR across age
groups with the lowest GFR in infants aged 6 months to
< 1 year of age (Fig. 3, Table 3). This trend is consistent
with age-related increases in eGFR and SCr across age
groups (p < 0.0001, One-way ANOVA, Table 3, Fig. 3)
with the largest difference observed in infants [32].
AKI prevalence in children with severe malaria
Using the different approaches to estimate bSCr we eval-
uated the prevalence of AKI on hospital admission in
1078 children with severe malaria (Figs. 2 and 5). AKI
was based on a single admission creatinine and the six
estimated bSCr values. AKI prevalence ranged from
15.6–43.4% (Fig. 5a, Additional file 1, Table S1). The
majority of AKI was stage 1 with staging estimates ran-
ging from: 7.7–24.3% Stage 1, 3.2–11.8% Stage 2, and
4.7–7.3% Stage 3 (Fig. 5a, Additional file 1, Table S1).
The prevalence of AKI with the three approaches show-
ing the best performance in estimating bSCr in the
Fig. 3 Estimated GFR and bSCr in healthy community children based on method to estimate bSCr. Graphs showing the GFR calculated off the
estimated bSCr using the Bedside Schwartz equation on the left y-axis in black and the estimated bSCr in grey on the right y-axis. The top row
represents approaches starting with an assumed GFR and back-calculating bSCr using either the Bedside Schwartz equation (a, c) or the Pottel
height-independent equation (b). The bottom row represents approaches to estimate bSCr directly using the upper limit of normal (d) or height
(e) and age (f) based estimates from community children. The eGFR for each graph was calculated using the Bedside Schwartz equation using
the bSCr and height at enrollment, where eGFR = (0.413*height)/bSCr
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Table 2 Agreement between measured and estimated serum creatinine in community children
Measured Estimated
bSCr back-calculated from GFR bSCr estimated directly
SCr bSCrGFRSchwartz120
(reference)
bSCrGFRPottel120 bSCrGFRSchwartz137 bSCrupperlimit bSCrheightCC bSCrageCC
Mean (SD) (mg/dL) 0.29 (0.08) 0.31 (0.05) 0.29 (0.05) 0.28 (0.04) 0.40 (0.06) 0.29 (0.04) 0.29 (0.04)
Median (IQR) (mg/dL) 0.28 (0.23, 0.33) 0.31 (0.28, 0.34) 0.28 (0.26, 0.30) 0.27 (0.25, 0.30) 0.39 (0.35, 0.42) 0.28 (0.26, 0.31) 0.28 (0.26, 0.30)
Wilcoxona – *** NS NS *** NS NS
Min, max (mg/dL) 0.19, 0.56 0.23, 0.34 0.22, 0.48 0.20, 0.44 0.35, 0.71 0.22, 0.44 0.23, 0.46
Correlation, SCr (r) – 0.495 0.485 0.495 0.407 0.495 0.485
Bias (mg/dL) – 0.025*** −0.002 (NS) −0.014*** 0.11*** −0.002 (NS) −0.002 (NS)
Precision (mg/dL) – 0.07 0.07 0.07 0.08 0.07 0.07
Accuracy
P10, % – 24% 35% 33% 8% 29% 35%
P30, % – 71% 79% 82% 33% 80% 78%
Proportional Bias – −0.66 ± 0.06 *** − 0.70 ± 0.06*** −0.81 ± 0.06*** −0.35 ± 0.07*** −0.91 ± 0.06*** −0.88 ± 0.06***
Standard deviation (SD), IQR: Inter-quartile range, r: Spearman’s rho, NS: Not significant, *p < 0.05, **p < 0.001, *** p < 0.0001
aWilcoxon signed rank test (paired) for comparison of entire distribution with measured creatinine
Bias: mean difference between estimated and measured creatinine. To estimate fixed bias, we compared value of the difference to a value of 0 using a one
sample t-test
Precision: one standard deviation of the Bias
Proportional bias: the slope of the regression line of the differences between estimated and measured creatinine against the average of estimated and measured
creatinine. A slope of 0 means no proportional bias
Accuracy reflects the percentage of estimated SCr within 10 or 30% of the measured SCr, where accuracy = [(measured SCr- estimated SCr)/measured SCr] *100
P value is the significance of the deviation of the slope from 0. ***p < 0.0001
Fig. 4 Bland Altman analysis comparing measured SCr in community children versus different methods to estimate bSCr. Graphs show the
difference in estimated baseline SCr (bSCr) and measured (mSCr) compared to the average. The top row represents approaches starting with an
assumed GFR and back-calculating bSCr using either the Bedside Schwartz equation (a, c) or the Pottel height-independent equation (b). The
bottom row represents approaches to estimate bSCr directly using the upper limit of normal (d) or height (e) and age (f) based estimates from
the community children. The bias represents the difference between the mSCr and estimated bSCr where the significance of bias was assessed
using a one sample t-test comparing the mean bias to 0. The precision is represented as one standard deviation of the mean difference.
Proportional bias was evaluated by testing if the slope of the linear regression model of the differences between estimated and measured
creatinine against the average of estimated and measured creatinine differed from zero. Proportional bias represents the slope (B1) + SE (standard
error) and the asterisks indicate whether the slope is statistically different from zero. Not significant (NS, where p > 0.05), *p < 0.05,
**p < 0.001, ***p < 0.0001
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Table 3 Estimates of bSCr and eGFR in healthy community children based on age at enrollment
Age < 1 years
(n = 18)
Age 1 to < 2 years
(n = 46)
Age 2 to < 5 years
(n = 192)
Age ≥ 5 years
(n = 33)
P value1
bSCr eGFR bSCr eGFR bSCr eGFR bSCr eGFR SCr eGFR
Reference
Measured SCr 0.23 (0.04) 127.3 (20.8) 0.25 (0.06) 135.9 (29.0) 0.29 (0.07) 138.2 (30.8) 0.37 (0.08) 136.0 (28.7) < 0.001 0.484
SCr estimated by back calculating from an assumed GFR
bSCrGFRSchwartz120
a 0.24 (0.01) 120 (0.0) 0.27 (0.01) 120 (0.0) 0.32 (0.03) 120 (0.0) 0.41 (0.04) 120 (0.0) < 0.001 –
bSCrGFRPottel120
b 0.23 (0.003) 126.8 (4.6) 0.25 (0.01) 131.9 (5.0) 0.29 (0.02) 132.7 (7.0) 0.39 (0.05) 126.8 (8.0) < 0.001 < 0.001
bSCrGFRSchwartz137
a 0.21 (0.009) 137 (0.0) 0.24 (0.01) 137 (0.0) 0.28 (0.02) 137 (0.0) 0.36 (0.03) 137 (0.0) < 0.001 < 0.001
SCr estimated directly
bSCrupperlimit
c 0.39 (0.0) 73.3 (3.1) 0.35 (0.0) 92.9 (4.5) 0.39 (0.03) 97.5 (6.8) 0.54 (0.07) 90.8 (7.1) < 0.001 < 0.001
bSCrCCheight
d 0.23 (0.01) 125.9 (0.8) 0.25 (0.01) 128.4 (0.9) 0.29 (0.02) 131.0 (1.4) 0.36 (0.03) 134.7 (1.2) < 0.001 < 0.001
bSCrCCage
e 0.23 (0.003) 121.8 (4.5) 0.25 (0.01) 128.8 (5.0) 0.29 (0.02) 132.5 (7.2) 0.37 (0.04) 131.6 (7.2) < 0.001 < 0.001
1P value calculated using ANOVA to evaluate mean differences across age categories
aBedside Schwartz equation (eGFR = 0.413*height/SCr) used to back calculate creatinine assuming a normal of 120 mL/min/1.73m2 or 137 mL/min/1.73m2 (mean
of the community children)
bPottel equation (eGFR = 107.3/(SCr/Q), where Q = 0.0270*age + 0.2329) used to back calculate creatinine assuming a normal of 120 mL/min per 1.73m2
cUpper limit using Ceriotti et al., Clin Chem 2008 54:3
dLinear regression model of height vs. creatinine using healthy community children to estimate baseline creatinine from model
eLinear regression model of age vs. creatinine using healthy community children to estimate baseline creatinine from model
Fig. 5 AKI prevalence and mortality across AKI stages and age categories in children with severe malaria. Bar graphs showing the frequency of
AKI (a, c) or AKI mortality (b, d) using different approaches to estimate baseline serum creatinine (bSCr). b AKI severity was associated with
increased mortality irrespective of method used to estimate bSCr (p < 0.0001 for all, Pearson’s Chi square test). c AKI prevalence differed across
age categories when GFR based methods were used to estimate bSCr *p < 0.05. There was no difference in AKI prevalence when using
approaches to directly estimate SCr (ns, p > 0.05). d AKI was associated with increased mortality across age categories
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community children were as follows: i) AKIGFRPottel120,
40.4% (95% CI 37.5–43.3); ii) AKIheightCC, 39.2% (95% CI
36.3–42.2); iii) AKIageCC, 39.2% (95% CI 36.3–42.2).
Using the Bedside Schwartz equation assuming an eGFR
of 120mL/min per 1.73m2 underestimated AKI in this
setting missing over 20% of AKI identified using
population-based approaches (AKIheightCC, AKIageCC). All
approaches based on a fixed eGFR estimate (AKIGFRSch-
wartz120, AKIGFRPottel120, AKIGFRSchwartz137) resulted in an
increase in AKI prevalence in infants aged 6 months to
1 year compared to the older age groups (Fig. 5c).
The Pottel equation had the highest area under the
ROC curve, along with the highest sensitivity to predict
mortality at 77.6%, and the highest risk ratio at 5.13
(95% CI 3.03–8.68) adjusting for child age and sex
(Table 4). Mortality in children diagnosed with AKI
using the Pottel equation was 13.6% overall and in-
creased across AKI stages from 9.8% in stage 1 AKI,
14.0% in stage 2 AKI and 25.3% in stage 3 AKI. The rela-
tionship between AKI and mortality was consistent
across age groups with change in mortality across age
groups (Fig. 5d).
Discussion
In the present study we evaluated six different ap-
proaches to estimate bSCr in Ugandan children. In this
undernourished population of Ugandan children, assum-
ing a normal GFR of 120 mL/min per 1.73m2 to calcu-
late estimated bSCr underestimated AKI but retained
good sensitivity to predict mortality. Of published
methods, the Pottel height-independent approach to es-
timate bSCr in our population of lean Ugandan children
was the most accurate and had the least bias. Further,
the Pottel height-independent equation showed the
strongest relationship with mortality in children with se-
vere malaria.
There is a physiological increase in GFR from birth to
age 2 [32]. A number of pediatric studies suggest using
age-based normative eGFR values in children < 2 years
of age to account for the physiological changes in GFR
in this age group [7, 8]. In the present study we observed
an increase in eGFR across age groups, but the eGFR
was greater than 120 mL/min per 1.73m2 across all age
groups, including infants, suggesting that using norma-
tive eGFR values in children < 2 years of age may not be
as applicable in Ugandan children. This emphasizes the
importance of nutritional status and body habitus when
selecting methods to estimate bSCr and the need for
evaluating and validating a range of equations. Efforts
are underway to evaluate eGFR equations in adults
across sub-Saharan Africa [15], and parallel efforts in
children would be advantageous to better understand
how measured GFR and estimated bSCr relate in this
setting.
Our results are consistent with a high prevalence of
AKI in children with severe malaria irrespective of age
[25], and challenge the paradigm that AKI in severe mal-
aria is more frequent in older children and adults [18].
The children in this study were 12 and under. Whether
our results apply to older children who are more likely
to have undergone puberty will need to be determined
in future studies. We demonstrate that AKI is common
across all age groups. There were no differences in mor-
tality across age groups in this pediatric population. Lar-
ger studies will be needed to evaluate whether there are
age-related differences in susceptibility to AKI and
whether there are age-related differences in outcomes in
pediatric populations.
The three approaches of back-calculating estimated
bSCr based on a fixed eGFR showed differences in AKI
prevalence across age groups with the highest prevalence
seen in infants and the lowest prevalence observed in
children < 5 years of age (Fig. 5c, Table S2). When com-
paring approaches of estimating bSCr in community
children, bSCr estimates were closest to the measured
value in infants. All approaches to estimate bSCr in the
study population had a significant proportional bias as
seen by a positive slope on the Bland-Altman plots in
Fig. 4, and all models except the upper limit of normal
underestimated bSCr in older children. As such, the
prevalence of AKI in infants is likely accurate, but AKI
may be underestimated in older children. In the present











Model Fit AKI Area
under ROCAIC BIC Sensitivity Specificity
AKISchwartz120 25 (3.4) 51 (15.1) 4.41 (2.78, 7.00) 0.473 − 6990.3 0.69 (0.64, 0.75) 67.1% 71.3%
AKIPottel120 17 (2.7) 59 (13.6) 5.13 (3.03, 8.68) 0.469 − 6994.0 0.70 (0.65, 0.75) 77.6% 62.4%
AKISchwartz137 17 (2.8) 59 (12.6) 4.50 (2.66, 7.62) 0.477 − 6986.2 0.68 (0.63, 0.73) 77.6% 59.2%
AKIupperlimit 43 (4.7) 33 (19.6) 4.17 (2.74, 6.36) 0.479 − 6984.1 0.65 (0.59, 0.71) 43.4% 86.5%
AKIheightCC 20 (3.1) 56 (13.3) 4.28 (2.61, 7.03) 0.477 −6986.3 0.69 (0.63, 0.74) 73.7% 63.4%
AKIageCC 18 (2.8) 58 (13.7) 4.99 (2.98, 8.34) 0.470 − 6993.6 0.70 (0.65, 0.75) 76.3% 63.5%
Risk ratio estimated using a generalized linear model with binomial family and log link adjusting for age and sex
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study the majority of the community children were < 5
years of age. A larger population of children > 5 years
and adolescents are needed to establish norms across
the pediatric age spectrum in this setting.
Accurate assessment of height in critically ill popula-
tions can be challenging, and appropriate measurement
tools are not always available in resource-constrained
settings. This study was able to assess the reliability of
height measures over time using mixed effects models
adjusting for child age and sex to correct individual-level
outliers as described [24, 25]. We identified several
heights that required adjustment based on the child’s in-
dividual growth trajectory or the mean height-for-age
score for the population. Given potential limitations in
obtaining accurate height measurements in critically ill
populations, including infection-control concerns in cer-
tain high-risk populations (e.g. Ebolavirus [33]), the val-
idation of age-based approaches to estimate bSCr in
hospitalized patients in LMIC settings is essential.
The Pottel equation was derived from a large hospital
database of normal creatinine in Belgian children and
differs from the Bedside Schwartz equation, which was
developed in children with chronic kidney disease. The
height independent Pottel equation (eGFR = 107.3/(Scr/
Q) uses age-based norms of creatinine defined by Q. Up-
dates to the height-independent equation have been sug-
gested to modify the calculation of Q by sex and age and
extend it into adolescence and early adulthood (Hoste(-
age) [34]). The updated Hoste(age) equation and use of
Q alone led to overestimation of creatinine in our study
population. Thus, the original Pottel equation assuming
a normal eGFR of 120 mL/min per 1.73m2 was the most
appropriate in our population and closely resembled the
linear regression estimates of bSCrageCC derived using
measured values from community children. With the ad-
vantage of not requiring a height measurement, the Pot-
tel age-based equation is more suitable for large
population-based studies.
In this study we included the upper limit of normal to
estimate AKI as this approach was used in the largest
prospective study of AKI in Ugandan children that was
conducted in 2055 hospitalized children aged 0–15 years
at Mulago National Referral Hospital [28]. The preva-
lence of AKI in the study by Imani et al., was 13.5%
overall, and was 5.4% in children with malaria [28]. In
the present study the prevalence of AKI in children that
met WHO severe malaria criteria on admission using
the upper limit of normal was nearly three-fold higher at
15.6% compared to 5.4% in the study by Imani et al., and
40.4% using our recommended approach of AKIPottel120.
Therefore, we estimate that the prevalence of AKI in the
study by Imani et al., would likely be between 27.2–
35.0% using more sensitive approaches of
bSCrGFRSchwartz120 or bSCrGFRPottel120 respectively. AKI is
a well-established risk factor for mortality in critically ill
populations. The ideal AKI definition should be sensitive
as small increases in creatinine are associated with in-
creased mortality [5, 10, 35]. Further, AKI is a risk factor
for the long-term development of chronic kidney disease
(CKD) in both adult and pediatric populations [25, 36–
41]. In Ugandan severe malaria survivors AKI is a risk
factor for long-term neurocognitive impairment and
behavioral problems [25, 42]. The use of sensitive AKI
definitions is important to identify children at risk of in-
hospital mortality, but also to identify children at risk
for post-discharge morbidity (e.g. repeated admissions,
chronic kidney disease, cardiovascular disease), and
mortality.
There were a number of limitations in this study. First,
we were unable to directly measure GFR in the studied
population using methodology such as iohexol clearance
and had to rely on using equations developed in other
contexts. None of the children with severe malaria had a
known bSCr, so we had to evaluate approaches to esti-
mate bSCr using healthy community children. As the
methods to estimate bSCR were derived from the com-
munity children, this likely contributed to the good per-
formance of the approaches. Additional prospective
studies are required to externally validate these ap-
proaches in an independent cohort of Ugandan children.
We were unable to rule out congenital malformations of
the genitourinary system in the healthy children, so it is
possible that children with clinically silent kidney disease
were included. However, children with a history of
chronic disease were not eligible for the study, and two
children with evidence of underlying kidney disease were
excluded from the study. It is possible some of the chil-
dren with severe malaria had underlying kidney disease
that made them susceptible to AKI and severe disease.
However, as malaria is an acute febrile illness that typic-
ally occurs in previously healthy children, we expect the
number of children with underlying kidney disease in
the severe malaria group to be low. None of the commu-
nity children had HIV-infection or a history of infection
requiring medical attention in the 4 weeks prior to
enrollment.
There are a number of strengths in this study. We
were able to combine two cohorts of healthy community
children and children with severe malaria to assess nor-
mal renal function in a relatively large population of
Ugandan children. As children were followed longitudin-
ally we were able to use the child’s growth trajectory to
identify height outliers. We were also able to assess AKI
in a population of children with severe malaria from the
same community as the healthy children. As the study
included children from 6 months of age, we were able to
evaluate methods to estimate bSCr during a period of
physiological changes in GFR. All children were
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genotyped for sickle cell anemia and we were able to
evaluate whether there were differences in SCr in com-
munity children with sickle cell trait, as there is evidence
that sickle cell trait may lead to more subtle changes in
kidney function [43] and increases risk of chronic kidney
disease in some [44, 45], but not all populations [46].
Children with sickle cell disease have hyperfiltration
[47–50] and increased tubular secretion of creatinine
[47, 51] contributing to lower bSCr levels. Additional re-
search is needed to understand how sickle cell trait and
sickle cell disease modifies normal kidney function, af-
fects bSCr estimation, and whether sickle cell anemia in-
creases the risk of severe malaria-associated AKI in the
population.
Conclusion
AKI is an important complication in hospitalized chil-
dren and is diagnosed based on a change in creatinine
from known or estimated bSCr. As AKI in LMIC is
often community-acquired, there is an urgent need to
identify the most appropriate approach to estimate bSCr
in low-income settings. We considered both height-
dependent and height-independent age-based ap-
proaches to estimate bSCr, and conclude that the Pottel-
height independent GFR estimating equation represents
the most appropriate equation for Ugandan children and
represents a promising approach to adapt to other LMIC
settings.
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